We have utilised a natural ligand of EPHB4, Ephrin B2, as an antigen recognition site of the CAR molecule, and these CAR‐T cells effectively recognised and eliminated EPHB4‐positive tumor cells.7 This evidence concerns the gene EFNB2 and neoplasm.